| Date |
Research Question / Title |
Unique ID |
Research Team |
|
July 20, 2021
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v7 RR
|
Infectious Disease
|
|
July 12, 2021
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602 RR
|
Epidemiology & Modelling
|
|
July 12, 2021
|
What is the epidemiology of variants and what are the implications for healthcare? [Evergreen]
|
EOC031801v8 RR
|
EOC
|
|
July 9, 2021
|
What is the incidence and duration of Long COVID cases?
|
EPM210601 RR
|
Epidemiology & Modelling
|
|
June 24, 2021
|
What is the epidemiology of variants and what are the implications for healthcare? [Evergreen]
|
EOC031801v7 RR
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
|
June 10, 2021
|
What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view?
|
EOC210502 RR
|
EOC
|
|
June 9, 2021
|
How has COVID-19 and the public health response to COVID-19 impacted mental health outcomes on children 5 to 18 years (school-age)?
|
PH021701 RR
|
Public Health
|
|
May 27, 2021
|
What are other jurisdictions offering for incentive-based COVID-19
vaccine campaigns?
|
EOC210501 RR
|
EOC
|
|
May 10, 2021
|
What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy?
|
EOC012201v2 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
April 6, 2021
|
How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals
|
CC210301 RR
|
Critical Care
|
|
March 30, 2021
|
What are the effects of the new COVID variants on transmission and school reopenings in pediatric populations?
|
PH030801 RR
|
Public Health
|
|
March 29, 2021
|
What impact does COVID-19 vaccination have on visitation policies and transmission rates in LTC?
|
LTC012501 RR
|
Long Term Care
|
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
|
March 15, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901 RR
|
EOC
|
|
March 12, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401 RR
|
Public Health
|
|
February 27, 2021
|
What is the final disposition of post-COVID patients who require chronic ventilation in the ICU?
|
CC011101 RR
|
Critical Care
|
|
February 26, 2021
|
What are the efficacies and outcomes of Point-of-Care/Antigen testing in Long Term care?
|
LTC020201 RR
|
Long Term Care
|
|
February 12, 2021
|
How effective is surveillance antigenic testing?
|
EOC012601 RR
|
EOC
|
